Literature DB >> 25006430

Rescue balloon pulmonary angioplasty in a rapidly deteriorating chronic thromboembolic pulmonary hypertension patient with liver failure and refractory infection.

Akihiro Tsuji1, Takeshi Ogo1, Jun Demachi1, Yusuke Ono1, Yoshihiro Sanda1, Yoshihiro Morita1, Tetsuya Fukuda1, Norifumi Nakanishi1.   

Abstract

Pulmonary endarterectomy (PEA) is the standard therapy for chronic thromboembolic pulmonary hypertension (CTEPH). Balloon pulmonary angioplasty (BPA) is an alternative therapy for such patients. Here we report the case of a 60-year-old woman who presented with severe CTEPH resulting in low cardiac output and liver failure. Her clinical status rapidly deteriorated after she developed a respiratory infection that was refractory to antibiotic treatment. PEA was risky because of her unstable hemodynamics, uncontrolled infection, and liver failure with jaundice. We thus performed rescue BPA. After 3 BPA procedures, her cardiac symptoms improved from World Health Organization functional class IV to II, and her jaundice resolved. The day after her final BPA procedure, her hemodynamics dramatically improved, and she continued to show improvement 3 months later. We thus suggest that BPA is a good treatment option in CTEPH patients with rapidly deteriorating heart failure and uncontrolled comorbidities.

Entities:  

Keywords:  balloon pulmonary angioplasty; chronic thromboembolic pulmonary hypertension (CTEPH); liver failure; right heart failure

Year:  2014        PMID: 25006430      PMCID: PMC4070762          DOI: 10.1086/675643

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  16 in total

1.  Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension.

Authors:  F Reichenberger; R Voswinckel; B Enke; M Rutsch; E El Fechtali; T Schmehl; H Olschewski; R Schermuly; N Weissmann; H A Ghofrani; F Grimminger; E Mayer; W Seeger
Journal:  Eur Respir J       Date:  2007-08-09       Impact factor: 16.671

Review 2.  Chronic thromboembolic pulmonary hypertension.

Authors:  Franco Piovella; Andrea M D'Armini; Marisa Barone; Victor F Tapson
Journal:  Semin Thromb Hemost       Date:  2006-11       Impact factor: 4.180

Review 3.  Chronic thromboembolic pulmonary hypertension.

Authors:  Gregory Piazza; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2011-01-27       Impact factor: 91.245

4.  Risk factors for pulmonary thromboendarterectomy.

Authors:  P O Daily; W P Dembitsky; S Iversen; K M Moser; W Auger
Journal:  J Thorac Cardiovasc Surg       Date:  1990-04       Impact factor: 5.209

5.  Long-term recovery of exercise ability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.

Authors:  Hitoshi Matsuda; Hitoshi Ogino; Kenji Minatoya; Hiroaki Sasaki; Norifumi Nakanishi; Shingo Kyotani; Junjiro Kobayashi; Toshikatsu Yagihara; Soichiro Kitamura
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

6.  Japanese single-center experience of surgery for chronic thromboembolic pulmonary hypertension.

Authors:  Hitoshi Ogino; Motomi Ando; Hitoshi Matsuda; Kenji Minatoya; Hiroaki Sasaki; Norifumi Nakanishi; Shingo Kyotani; Hideaki Imanaka; Soichiro Kitamura
Journal:  Ann Thorac Surg       Date:  2006-08       Impact factor: 4.330

7.  Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism.

Authors:  Cecilia Becattini; Giancarlo Agnelli; Raffaele Pesavento; Mauro Silingardi; Renzo Poggio; Maria Rita Taliani; Walter Ageno
Journal:  Chest       Date:  2006-07       Impact factor: 9.410

8.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

9.  Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension.

Authors:  Masaharu Kataoka; Takumi Inami; Kentaro Hayashida; Nobuhiko Shimura; Haruhisa Ishiguro; Takayuki Abe; Yuichi Tamura; Motomi Ando; Keiichi Fukuda; Hideaki Yoshino; Toru Satoh
Journal:  Circ Cardiovasc Interv       Date:  2012-11-06       Impact factor: 6.546

10.  Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension.

Authors:  Hiroki Mizoguchi; Aiko Ogawa; Mitsuru Munemasa; Hiroshi Mikouchi; Hiroshi Ito; Hiromi Matsubara
Journal:  Circ Cardiovasc Interv       Date:  2012-11-27       Impact factor: 6.546

View more
  2 in total

Review 1.  Interventional Therapy for Pulmonary Embolism.

Authors:  Alan B Lumsden; Erik Suarez
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec

Review 2.  Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Authors:  Amanda Lloji; Urvashi Hooda; Jayakumar Sreenivasan; Ramin Malekan; Wilbert S Aronow; Gregg M Lanier
Journal:  Am J Cardiovasc Dis       Date:  2021-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.